Wells Fargo’s Aethlon Medical AEMD Stock Holding History

Wells Fargo’s Portfolio AEMD Stock Details AEMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$2	Hold	1	–	–	﹤0.01%	7209
2026 Q1	$6	Hold	1	–	–	﹤0.01%	7004
2025 Q4	$7	Hold	1	–	–	﹤0.01%	6920
2025 Q3	$19	Hold	1	–	–	﹤0.01%	6709
2025 Q2	$31	Hold	1	–	–	﹤0.01%	6674
2025 Q1	$76	Hold	1	–	–	﹤0.01%	6399
2024 Q4	$181	Hold	1	–	–	﹤0.01%	6371
2024 Q3	$98	Hold	1	–	–	﹤0.01%	6281
2024 Q2	$105	Hold	1	–	–	﹤0.01%	6247
2024 Q1	$386	Hold	1	–	–	﹤0.01%	6337
2023 Q4	$504	Hold	1	–	–	﹤0.01%	6378
2023 Q3	$519	Hold	1	–	–	﹤0.01%	6356
2023 Q2	$821	Hold	1	–	–	﹤0.01%	6372
2023 Q1	$871	Hold	1	–	–	﹤0.01%	6419
2022 Q4	$626	Hold	1	–	–	﹤0.01%	6323
2022 Q3	$1K	Hold	1	–	–	﹤0.01%	6255
2022 Q2	$2K	Hold	1	–	–	﹤0.01%	6282
2022 Q1	$3K	Hold	1	–	–	﹤0.01%	6564
2021 Q4	$4K	Hold	1	–	–	﹤0.01%	6733
2021 Q3	$8K	Hold	1	–	–	﹤0.01%	6262
2021 Q2	$10K	Hold	1	–	–	﹤0.01%	6132
2021 Q1	$4K	Hold	1	–	–	﹤0.01%	6528
2020 Q4	$5K	Hold	1	–	–	﹤0.01%	6131
2020 Q3	$3K	Hold	1	–	–	﹤0.01%	6070
2020 Q2	$4K	Hold	1	–	–	﹤0.01%	5997
2020 Q1	$3K	Hold	1	–	–	﹤0.01%	5920
2019 Q4	$2K	Buy	+1	New	+$12K	﹤0.01%	6149

Other funds holding AEMD

HRT Financial New York $54.8B AUM 81.03% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return

Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return

Shay Capital New York $1.56B AUM 46.17% 1-Year Est. Return

Virtu Financial New York $3.18B AUM 65.92% 1-Year Est. Return

Ikarian Capital Dallas, Texas $928M AUM 596.14% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

SRL

Scientech Research LLC Jersey City, New Jersey $123M AUM 198.31% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

TRCT

Tower Research Capital (TRC) New York $4.08B AUM 58.77% 1-Year Est. Return

Wells Fargo's AEMD Position: Q2 2026 in Review

Wells Fargo held its Aethlon Medical (AEMD) position steady in Q2 2026 at 1 share worth $2. The position accounts for ﹤0.01% of the portfolio, ranked #7209.

Wells Fargo first reported a position in AEMD in Q4 2019 and has held it in 27 quarters since. The position peaked at $10K in Q2 2021. 15 funds tracked by Wall St. Rank hold AEMD as of Q2 2026.

Wells Fargo held 1 share of Aethlon Medical worth $2 as of Q2 2026.
Wells Fargo left its Aethlon Medical share count unchanged in Q2 2026.
Aethlon Medical made up ﹤0.01% of Wells Fargo's portfolio in Q2 2026, its #7209 holding.
Wells Fargo first reported a position in Aethlon Medical in Q4 2019 and has held it in 27 quarters since.
Wells Fargo's Aethlon Medical position peaked at $10K in Q2 2021.
15 funds tracked by Wall St. Rank held Aethlon Medical as of Q2 2026.

Based on Wells Fargo's 13F filing for Q2 2026, filed 14 Aug 2026.